[68Ga]Ga-FAPI-46 has demonstrated efficacy in assessing bleomycin-induced idiopathic pulmonary fibrosis by targeting highly expressed FAP cells, showing promising applications [8]. Here, FAP is linked to idiopathic pulmonary fibrosis.